Pre-clinical evaluation of new adjuvant formulations to improve the immunogenicity of the malaria vaccine RTS,S/AS02A.
Explore this paper's citation graph
Summary
RTS,S/AS01B is a safe and immunogenically superior formulation for cellular responses, in comparison with the RTS, S/AS02A-standard.
- Type
- article
- Published
- 2006-10-30
- Cited by
- 104
- References
- 34
- OpenAlex
- https://openalex.org/W16904798
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:27977753
Keywords
Art, Medicine, Humanities
References
- Balancing risks on the backs of the poor
- The MHC class I genes of the rhesus monkey. Different evolutionary histories of MHC class I and II genes in primates.
- Pre-clinical evaluation of the malaria vaccine candidate P. falciparum MSP1(42) formulated with novel adjuvants or with alum.
- Conquering the intolerable burden of malaria: what's new, what's needed: a summary.
- Delineation of a CpG Phosphorothioate Oligodeoxynucleotide for Activating Primate Immune Responses In Vitro and In Vivo1
- Assay, purification and characterization of a recombinant malaria circumsporozoite fusion protein by high-performance liquid chromatography.
- CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults
- Malaria vaccines in development
- Immune effector mechanisms in malaria.
- Evolutionary stability of transspecies major histocompatibility complex class II DRB lineages in humans and rhesus monkeys.
- A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S/AS02A and MVA-CS.
- Development of RTS,S/AS02: a purified subunit-based malaria vaccine candidate formulated with a novel adjuvant
- Evaluation of Elispot assays: influence of method and operator on variability of results.
- Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial.
- An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model.
- Follow‐up of Gambian children recruited to a pilot safety and immunogenicity study of the malaria vaccine SPf66
- Plasmodium falciparum: immunogenicity of circumsporozoite protein constructs produced in Escherichia coli.
- Cutaneous delayed-type hypersensitivity (DTH) in a multi-formulation comparator trial of the anti-falciparum malaria vaccine candidate RTS,S in rhesus macaques.
- Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial.
- Evolution of the Class II Major Histocompatibility Complex Alleles in Higher Primates
Cited by
- A Randomized Trial Assessing the Safety and Immunogenicity of AS01 and AS02 Adjuvanted RTS,S Malaria Vaccine Candidates in Children in Gabon
- Development of a Novel Virus-Like Particle Vaccine Platform That Mimics the Immature Form of Alphavirus
- Unmet needs in modern vaccinology: adjuvants to improve the immune response.
- Delivery strategies to enhance oral vaccination against enteric infections.
- Recent developments in malaria vaccinology.
- Immune responses to "Plasmodium falciparum" in Mozambican infants receiving Intermittent Preventive Treatment with Sulfadoxine Pyrimethamine
- Ad35.CS.01 - RTS,S/AS01 Heterologous Prime Boost Vaccine Efficacy against Sporozoite Challenge in Healthy Malaria-Naïve Adults
- Liposome Adjuvants: Simultaneous Induction of Innate and Adaptive Immunity is Key to Success
- Tissue Distribution of Memory T and B Cells in Rhesus Monkeys following Influenza A Infection
- En busca de una vacuna anti-malárica
- Prophylactic and therapeutic implications of toll‐like receptor ligands
- A Potent Malaria Transmission Blocking Vaccine Based on Codon Harmonized Full Length Pfs48/45 Expressed in Escherichia coli
- Randomized Controlled Trial of RTS,S/AS02D and RTS,S/AS01E Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children
- Induction of Plasmodium falciparum-Specific CD4+ T Cells and Memory B Cells in Gabonese Children Vaccinated with RTS,S/AS01E and RTS,S/AS02D
- Expression of genes associated with immunoproteasome processing of major histocompatibility complex peptides is indicative of protection with adjuvanted RTS,S malaria vaccine.
- Poly(I:C) is an effective adjuvant for antibody and multi-functional CD4+ T cell responses to Plasmodium falciparum circumsporozoite protein (CSP) and αDEC-CSP in Non Human Primates
- Genome-based vaccine design: the promise for malaria and other infectious diseases.
- Evaluation of the safety and immunogenicity of Plasmodium falciparum apical membrane antigen 1, merozoite surface protein 1 or RTS,S vaccines with adjuvant system AS02A administered alone or concurrently in rhesus monkeys.
- Molecular vaccines for malaria
- Evaluation of RTS,S/AS02A and RTS,S/AS01B in Adults in a High Malaria Transmission Area
Related papers
No related papers recorded.